+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "HIV Clinical Trial"

Global HIV Clinical Trials Market by Phase (Phase I, Phase II, Phase III), Study Design (Expanded Access Studies, Interventional Studies, Observational Studies), Sponsor - Forecast 2024-2030 - Product Thumbnail Image

Global HIV Clinical Trials Market by Phase (Phase I, Phase II, Phase III), Study Design (Expanded Access Studies, Interventional Studies, Observational Studies), Sponsor - Forecast 2024-2030

  • Report
  • March 2024
  • 181 Pages
  • Global
From
HIV Clinical Trials Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F - Product Thumbnail Image

HIV Clinical Trials Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F

  • Report
  • November 2023
  • 177 Pages
  • Global
From
Global HIV Clinical Trials Market Size, Share & Trends Analysis Report by Phase (Phase I, Phase II, Phase III, Phase IV), by Study Design (Interventional, Expanded Access), by Sponsor, by Region, and Segment Forecasts, 2022-2030 - Product Thumbnail Image

Global HIV Clinical Trials Market Size, Share & Trends Analysis Report by Phase (Phase I, Phase II, Phase III, Phase IV), by Study Design (Interventional, Expanded Access), by Sponsor, by Region, and Segment Forecasts, 2022-2030

  • Report
  • July 2022
  • 98 Pages
  • Global
From
Global HIV Treatment Clinical Trial Pipeline Highlights - 2022 - Product Thumbnail Image

Global HIV Treatment Clinical Trial Pipeline Highlights - 2022

  • Report
  • August 2022
  • Global
From
C-C Chemokine Receptor Type 5 (CHEMR13 or HIV 1 Fusion Coreceptor or CD195 or CCR5) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

C-C Chemokine Receptor Type 5 (CHEMR13 or HIV 1 Fusion Coreceptor or CD195 or CCR5) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • September 2022
  • 89 Pages
  • Global
From
  • 5 Results (Page 1 of 1)
Loading Indicator

The HIV Clinical Trial market is a subset of the larger Clinical Trials market, which focuses on the development of treatments and preventative measures for HIV/AIDS. HIV Clinical Trials are conducted to evaluate the safety and efficacy of new drugs, vaccines, and other treatments for HIV/AIDS. These trials are conducted in accordance with the ethical principles of the Declaration of Helsinki and the International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH). The HIV Clinical Trial market is highly regulated, with stringent requirements for the design, conduct, and reporting of clinical trials. The market is also subject to a variety of legal and ethical considerations, including patient privacy and informed consent. Companies in the HIV Clinical Trial market include Gilead Sciences, Merck, ViiV Healthcare, Janssen Pharmaceuticals, and GlaxoSmithKline. Show Less Read more